SCHEMBL141348

SCHEMBL141348

Cc1cc(=O)[nH]c2cc(N)ccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 8/20 0.66
KDM4E B2RXH2 6/20 0.62
GAA P10253 5/20 0.62
GLA P06280 4/20 0.62
ALDH1A1 P00352 4/20 0.62
HPGD P15428 4/20 0.62
TP53 P04637 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
AR P10275 2/20 0.60
CYP1A2 P05177 1/20 0.58
CYP2C19 P33261 1/20 0.58
PARP1 P09874 1/20 0.55
HSD17B10 Q99714 3/20 0.54
TNKS O95271 1/20 0.50
LMNA P02545 1/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
CA9 Q16790 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29400852 1.00 TNKS2 (0.66) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL1420703 0.85 LMNA (0.62) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL8049063 0.80 AR (0.55) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL2795205 0.80 KDM4E (0.67) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL592109 0.77 KDM4E (1.00) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL13264599 0.77 KDM4E (0.62) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL1378769 0.77 TNKS2 (0.75) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL8064223 0.77 KDM4E (0.62) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL2798886 0.77 KDM4E (0.62) TNKS2KDM4EGAAGLAALDH1A1
SCHEMBL29532206 0.77 KDM4E (1.00) TNKS2KDM4EGAAGLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 894 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235337-A1 OPTICAL METHOD TO ENHANCE DETECTION VISIBILITY USING BRIGHT EMISSIVE PROBE KLA CORPORATION (US) 2025-11-13 WO claimed
US-20250346805-A1 OPTICAL METHOD TO ENHANCE DETECTION VISIBILITY USING BRIGHT EMISSIVE PROBE KLA CORP (US) 2025-11-13 US claimed
US-20230201624-A1 NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION IMMUNOLIGHT, LLC (US) 2023-06-29 US claimed
CN-112557355-B Method for detecting bismuth ions in biological fluid by rare earth fluorescent probe 东南大学 2023-03-21 CN claimed
CN-114058422-B Mannich ashless dispersant and preparation method thereof 中国石油天然气股份有限公司 2022-08-05 CN claimed
CN-114057916-A Preparation method of antioxidant ashless dispersant for lubricating oil 中国石油天然气股份有限公司 2022-02-18 CN claimed
CN-114058422-A Mannich ashless dispersant and preparation method thereof 中国石油天然气股份有限公司 2022-02-18 CN claimed
CN-112557355-A Method for detecting bismuth ions in biological fluid by rare earth fluorescent probe 东南大学 2021-03-26 CN claimed
EP-2453927-B1 LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES UNIV DENMARK TECH DTU (DK) 2019-05-15 EP claimed
US-9505977-B2 Gadolinium-loaded gel scintillators for neutron and antineutrino detection The United States of America Department of Energy (US) 2016-11-29 US claimed
US-6361923-B1 Laser ablatable material and its use INTERNATIONAL BUSINESS MACHINES CORPORATION 2002-03-26 US claimed
US-20010045529-A1 Double-resonance-absorption microscope OLYMPUS CORPORATION (JP) 2001-11-29 US claimed
EP-0767912-A4 LUMINESCENT LANTHANIDE CHELATES AND METHODS OF USE UNIV CALIFORNIA (US) 2001-08-22 EP claimed
US-5656433-A LABELS, DETECTORS, DIAGNOSTIC, THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-08-12 US claimed
US-5639615-A COUMARIN (OR QUINOLONE-)LIKE SENSITIZER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-06-17 US claimed
US-5622821-A COUMARIN OR QUINOLONE SENSITIZER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-04-22 US claimed
EP-0767912-A1 LUMINESCENT LANTHANIDE CHELATES AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-04-16 EP claimed
WO-1996000901-A1 LUMINESCENT LANTHANIDE CHELATES AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-01-11 WO claimed
US-4997920-A Dyeing polyolefins CIBA-GEIGY CORPORATION (US) 1991-03-05 US claimed
US-4670486-A Polymer composition pigmented with copper or nickel complexes of ligands containing a semicarbazone moiety CIBA-GEIGY CORPORATION (US) 1987-06-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230201624-A1 NON-INVASIVE ENERGY UPCONVERSION METHODS AND SYSTEMS FOR IN-SITU PHOTOBIOMODULATION MAVS, NLN, FURIN TNKS2 755/4885KDM4E 4490/4885GAA 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.